Clinical implication of autoantibodies in patients with systemic rheumatic diseases (Q37754648)

22 August 2017

Clinical implication of autoantibodies in patients with systemic rheumatic diseases (English)

1 reference

22 August 2017

1 reference

Minoru Satoh

1

1 reference

22 August 2017

Edward Kl Chan

2

1 reference

22 August 2017

Eric S Sobel

3

1 reference

22 August 2017

Donald L Kimpel

4

1 reference

22 August 2017

Yoshioki Yamasaki

5

1 reference

22 August 2017

Sonali Narain

6

1 reference

22 August 2017

Rizwan Mansoor

7

1 reference

22 August 2017

Westley H Reeves

8

1 reference

22 August 2017

language of work or name

1 reference

1 September 2007

1 reference

Expert Review of Clinical Immunology

22 August 2017

1 reference

22 August 2017

3

1 reference

22 August 2017

5

1 reference

22 August 2017

721-738

1 reference

The 1982 revised criteria for the classification of systemic lupus erythematosus

22 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

The emergence of multiplexed technologies as diagnostic platforms in systemic autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Multiplexed protein array platforms for analysis of autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Antinuclear antibodies in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Range of antinuclear antibodies in "healthy" individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Evaluation of diagnostic tests for antinuclear antibodies in rheumatological practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Immunofluorescence microscopy is superior to fluorescent beads for detection of antinuclear antibody reactivity in systemic lupus erythematosus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Nucleolar staining cannot be used as a screening test for the scleroderma marker anti-RNA polymerase I/III antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Disruption of GW bodies impairs mammalian RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

A phosphorylated cytoplasmic autoantigen, GW182, associates with a unique population of human mRNAs within novel cytoplasmic speckles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

The role of GW/P-bodies in RNA processing and silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Autoimmune targeting of key components of RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Ge-1 is a central component of the mammalian cytoplasmic mRNA processing body

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Unique and shared features of Golgi complex autoantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

MCTD: a concept which stood the test of time.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

The titre of anti-centromere antibodies: its relationship to Raynaud's phenomenon and vascular occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Human lupus autoantibodies against NMDA receptors mediate cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Transient autoimmunity related to maternal autoantibodies: neonatal lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Idiopathic inflammatory myopathies - myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Autoantibodies to RNA helicase A: a new serologic marker of early lupus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Development of systemic sclerosis in a patient with systemic lupus erythematosus and topoisomerase I antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune muscle disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Quantitation of autoantibodies in systemic autoimmune diseases: clinically useful?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/methylprednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Predictive value of autoantibodies for activity of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Antinuclear antibody in systemic sclerosis (scleroderma).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Autoantibodies in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Differences in autoantibody response to Th/To between systemic sclerosis and other autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Methods of choice for diagnostic antinuclear antibody (ANA) screening: benefit of adding antigen-specific assays to immunofluorescence microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Antibodies reacting with ribosomal ribonucleoprotein in connective tissue diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Identification and chemical synthesis of a ribosomal protein antigenic determinant in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Anti-topoisomerase I antibodies in systemic lupus erythematosus as a marker of severe nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Polymyositis and dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Unique characteristics of systemic sclerosis sine scleroderma-associated interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Autoantibodies against the replication protein A complex in systemic lupus erythematosus and other autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Autoantibody responses in Chinese hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Anti-centromere antibodies in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Distinct recognition of antibodies to centromere proteins in primary Sjogren's syndrome compared with limited scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Systemic sclerosis-associated Sjögren's syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Antinuclear, anticytoplasmic, and anti-Sjogren's syndrome antigen A (SS-A/Ro) antibodies in female blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Anti-DFS70 antibodies in 597 healthy hospital workers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Antibodies against heat shock proteins in environmental stresses and diseases: friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Sequential autoantigenic determinants of the small nuclear ribonucleoprotein Sm D shared by human lupus autoantibodies and MRL lpr/lpr antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Autoantibodies to RNA polymerase II are common in systemic lupus erythematosus and overlap syndrome. Specific recognition of the phosphorylated (IIO) form by a subset of human sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Advances and applications of multiplexed diagnostic technologies in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Association of anti-nucleoprotein autoantibodies with upregulation of Type I interferon-inducible gene transcripts and dendritic cell maturation in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

A novel autoantibody to a 155-kd protein is associated with dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.3.5.721

21 January 2018

Identifiers

DOI

10.1586/1744666X.3.5.721

1 reference

22 August 2017

1 reference